PEDOT was synthesized by chemical polymerisation and characterised for its electrochemical insights. Three different anode configuration, namely graphite plate (GP), carbon cloth (CC) and graphite felt (GF) were then loaded with a fixed amount of PEDOT (2.5 mg/m(2)) denoted as GP-P, CC-P and GF-P respectively. The PEDOT coating improved the electrochemical characteristics and electron transfer capabilities of the anodes. They also contributed for enhanced MFC performances with maximum energy generation along with coulombic efficiency than the unmodified anodes. The morphological characteristics like higher surface area and open structure of felt material promoted both microbial formation and electrochemical active area. A maximum current density of 3.5A/m(2) was achieved for GF-P with CE and COD of 51% and 86% respectively. Thus, the GF-P anode excelled among the studied anodes with synergetic effect of PEDOT coating and structural configuration, making it as a potential optimum anode for MFC application.
Clenbuterol (CLB) is an antibiotic and illegal growth promoter drug that has a long half-life and easily remains as residue and contaminates the animal-based food product that leads to various health problems. In this work, electrochemical immunosensor based on poly(3,4-ethylenedioxythiophene)/graphene oxide (PEDOT/GO) modified screen-printed carbon electrode (SPCE) for CLB detection was developed for antibiotic monitoring in a food product. The modification of SPCE with PEDOT/GO as a sensor platform was performed through electropolymerization, while the electrochemical assay was accomplished while using direct competitive format in which the free CLB and clenbuterol-horseradish peroxidase (CLB-HRP) in the solution will compete to form binding with the polyclonal anti-clenbuterol antibody (Ab) immobilized onto the modified electrode surface. A linear standard CLB calibration curve with R² = 0.9619 and low limit of detection (0.196 ng mL-1) was reported. Analysis of milk samples indicated that this immunosensor was able to detect CLB in real samples and the results that were obtained were comparable with enzyme-linked immunosorbent assays (ELISA).
Herein we report for the first time a series of 2-benzamido-N-(2-oxo-4-(methyl/trifluoromethyl)-2H-chromen-7-yl) benzamide 3a-f and substituted quinazolin-4(3H)-ones and 2H-benzo[e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxides (5, 6, 8 and 10a-c) as selective inhibitors of the tumor associated hCA IX and XII isoforms. Among the compounds reported the trifluoromethyl derivative 3d resulted the most potent against these CA isoforms with KIs of 10.9 and 6.7nM.